Torrent pharma gets CDSCO nod to market additional strength of Amlodipine,Olmesartan Medoxomil FDC Medical Dialogues Team22 Nov 2021 12:04 PM GMTNew Delhi: Approving the waiver of the phase 3 clinical trial, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
NPPA fixes retail price of 23 formulations; details Medical Dialogues Team27 Sep 2021 11:07 AM GMTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, h...
Nuts and Bolts of latest Hypertension Guidelines - The emphasis on combination therapy Dr. Prem Aggarwal6 Aug 2021 7:15 AM GMTHypertension, marked as a disorder with invading effects, shows increasing prevalence in different forms all across the globe. For example, in India...
Reviewing the triple A in cardiology: The role of amlodipine-atenolol in angina relief dr. Abhimanyu Uppal27 July 2021 7:15 AM GMTAmlodipine, a charged dihydropyridine-type (DHP) calcium channel blocker (CCB), has been widely used to treat hypertension. (1) Amlodipine...
Amlodipine and Telmisartan combination offers swift, effective BP control along with end-organ protection in hypertensive patients with diabetes: Study Dr. Prem Aggarwal7 July 2021 7:15 AM GMTHypertension and diabetes - the deadly duo!Hypertension or high blood pressure (BP), the leading cause of mortality, affects nearly 1.39 billion peopl...
22 drug samples including Sun Pharma Rosuvas fail to qualify CDSCO test Medical Dialogues Team4 July 2021 6:00 AM GMTSun Pharma clarified that two batches of Rosuvas 20 were found spurious
BP control in Severe Hypertension: Combination of Amlodipine and Telmisartan more efficacious than monotherapy Hina Zahid5 Jun 2021 5:45 AM GMTIndia at the brink of a hypertension epidemic!Globally >1 billion adults suffer from hypertension and this figure is expected to rise to 1.5 billion...
Amlodipine and Atenolol - The two most time-tested anti-hypertensives of 21st century dr. Abhimanyu Uppal27 April 2021 7:12 AM GMTCardiovascular disease is the leading cause of death worldwide, and hypertension is a modifiable risk factor for cardiovascular disease. Risk...
Amlodipine, Telmisartan Combination better than Monotherapy: TEAMSTA 5 Study Dr. Prem Aggarwal13 April 2021 7:15 AM GMTThe hypertensive pressure continues to mount!Hypertension or high blood pressure (BP) affects 1.39 billion people worldwide. Nearly 25% men and 20%&nbs...
NPPA Fixes Retail Price Of 41 Formulations; Details Medical Dialogues Team19 March 2021 8:14 AM GMTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, h...
Efficacy of Amlodipine as an anti Hypertensive in India: Results from a real-world study Dr. Kamal Kant Kohli8 Dec 2020 6:32 AM GMTNew Delhi: Amlodipine prescribed as monotherapy or add-on therapy during routine clinical practice significantly reduced BP in≤45- and≥65-year-old...
Azelnidipine versus Amlodipine in hypertensive diabetics with albuminuria: Review Dr. Prem Aggarwal27 Nov 2020 7:15 AM GMTHypertension is common among diabetics and those who have chronic kidney disease. Both hypertension and diabetes are associated with increased...
